封面
市場調查報告書
商品編碼
1550568

大麻二酚 (CBD) 市場:按成分類型、按產品、按應用、按配銷通路、按地區

Cannabidiol Market, By Source Type, By Product, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球大麻二酚(CBD)市場規模為81.2億美元,預計2031年將達234.1億美元,2024年至2031年複合年成長率為16.3%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 81.2億美元
實際資料 2019-2023 預測期 2024-2031
預測 2024-2031 年複合年成長率: 16.30% 2031年價值預測 234.1億美元
圖:2024 年大麻二酚 (CBD)市場佔有率(%),按地區分類
大麻二酚市場-IMG1

大麻二酚(CBD)是大麻植物(如大麻和大麻)中發現的主要大麻素之一。大麻二酚 (CBD) 具有一些潛在的醫療和治療作用,但沒有 THC(Delta-9-四氫大麻酚)的精神作用。提高人們對 CBD 對失眠、慢性疼痛、焦慮和癲癇等疾病的治療特性的認知,可能會支持大麻二酚 (CBD) 注入產品的採用。此外,大麻在多個國家已實現醫療用途合法化,為大麻二酚 (CBD) 製造商和供應商提供了新的機會。各種研究正在進行中,以檢驗CBD 的功效和安全性,這可能會進一步擴大 CBD 產品未來的商業化前景。

市場動態:

醫用大麻的日益合法化和大麻產品的越來越多的採用可能會推動全球大麻二酚(CBD)市場的成長。公司增加對大麻研究和新產品推出的投資可以推動市場成長。此外,文明病、精神疾病和慢性病的盛行率不斷上升將推動對治療性 CBD 產品的需求。然而,某些法規可能會阻礙市場成長。缺乏有關功效和安全性的臨床試驗資料也阻礙了市場成長。同時,它在食品、飲料和個人保健產品中的採用正在增加,可能提供市場擴張機會。

本研究的主要特點

本報告對全球大麻二酚(CBD)市場進行了詳細分析,包括年複合成長率(CAGR%)。已發布。

它還揭示了各個細分市場的潛在商機,並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球大麻二酚 (CBD) 市場的主要企業。

本研究涵蓋的主要企業包括 CV Sciences, Inc.、Isodiol、Medical Marijuana Inc.、Aurora Cannabis、ENDOCA、Elixinol 和 GAIA Botanicals LLC。

該報告的見解將幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球大麻二酚 (CBD) 市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過分析全球大麻二酚(CBD)市場時所使用的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球大麻二酚 (CBD) 市場 – COVID-19 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球大麻二酚(CBD)市場,依成分類型,2019-2031(十億美元)

  • 大麻

第6章全球大麻二酚(CBD)市場,按產品,2019-2031(十億美元)

  • 酊劑
  • 栓劑
  • 經皮吸收貼片
  • 電子煙油
  • 隔離群
  • 奶油滾
  • 膠囊
  • 錠劑
  • 其他

第7章 全球大麻二酚 (CBD) 市場,按應用分類,2019-2031 年(十億美元)

  • 醫療保健
  • 慢性疼痛
  • 精神障礙
  • 癌症
  • 其他
  • 個人使用
  • 藥品
  • 健康
  • 食品/飲料
  • 個人護理/化妝品
  • 食品補充品
  • 其他

第8章全球大麻二酚(CBD)市場,按地區,2019-2031(十億美元)

  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第9章 競爭格局

  • 公司簡介
    • ENDOCA
    • Cannoid LLC
    • Medical Marijuana Inc.
    • Folium Biosciences
    • Elixinol
    • NuLeaf Naturals LLC
    • Isodiol International Inc.
    • Pharmahemp doo
    • Aurora Cannabis Inc.
    • CV Sciences
    • Medterra CBD
    • Canopy Growth Corporation
    • Aphria, Inc.
    • GW Pharmaceuticals Plc
    • Organigram Holding Inc.

第10章分析師建議

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4613

Global cannabidiol market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 8.12 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 16.30% 2031 Value Projection: US$ 23.41 Bn
Figure. Cannabidiol Market Share (%), By Region 2024
Cannabidiol Market - IMG1

Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the therapeutic properties of CBD for conditions like insomnia, chronic pain, anxiety, and epilepsy can boost adoption of cannabidiol-infused products. Moreover, legalization of cannabis in several countries for medical use offer new opportunities for cannabidiol manufacturers and vendors. Various studies examining the efficacy and safety of CBD are underway, which can further augment the commercialization scope of CBD products in the future.

Market Dynamics:

Rising legalization of medical cannabis and growing adoption of cannabis-based products can drive the global cannabidiol market growth. Increasing investments by companies in cannabis research and new product launches can drive the market growth. Furthermore, rising prevalence of lifestyle diseases, mental health disorders, and chronic conditions boosts demand for therapeutic CBD products. However, certain regulations can hamper the market growth. Lack of clinical trials data on efficacy and safety can also hamper the market growth. Meanwhile, growing adoption in food & beverages, and personal care products can offer opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global cannabidiol market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cannabidiol market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol and GAIA Botanicals LLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global cannabidiol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol market

Detailed Segmentation-

  • By Source Type
    • Hemp
    • Marijuana
  • By Product
    • Oil
    • Tinctures
    • Suppository
    • Transdermal patches
    • Vape Oil
    • Isolates
    • Creams and Roll-on
    • Capsules
    • Tablet
    • Others
  • By Application
    • Medical
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
    • Personal Use
    • Pharmaceuticals
    • Wellness
    • Food & Beverages
    • Personal Care & Cosmetics
    • Nutraceuticals
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • ENDOCA
    • Cannoid LLC
    • Medical Marijuana Inc.
    • Folium Biosciences
    • Elixinol
    • NuLeaf Naturals LLC
    • Isodiol International Inc.
    • Pharmahemp d.o.o.
    • Aurora Cannabis Inc.
    • CV Sciences
    • Medterra CBD
    • Canopy Growth Corporation
    • Aphria, Inc.
    • GW Pharmaceuticals Plc
    • Organigram Holding Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source Type
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cannabidiol Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cannabidiol Market, By Source Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hemp
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Marijuana
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cannabidiol Market, By Product, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oil
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Tinctures
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Suppository
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transdermal patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Vape Oil
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Isolates
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Creams and Roll-on
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Capsules
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Tablet
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cannabidiol Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Medical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
  • Personal Use
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmaceuticals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wellness
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Food & Beverages
  • Personal Care & Cosmetics
  • Nutraceuticals
  • Others

8. Global Cannabidiol Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • ENDOCA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cannoid LLC
    • Medical Marijuana Inc.
    • Folium Biosciences
    • Elixinol
    • NuLeaf Naturals LLC
    • Isodiol International Inc.
    • Pharmahemp d.o.o.
    • Aurora Cannabis Inc.
    • CV Sciences
    • Medterra CBD
    • Canopy Growth Corporation
    • Aphria, Inc.
    • GW Pharmaceuticals Plc
    • Organigram Holding Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact